Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D01NTM
|
||||
Former ID |
DNC003713
|
||||
Drug Name |
VER-5593
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [527037] | ||
Structure |
Download2D MOL |
||||
Formula |
C12H17FN2S
|
||||
Canonical SMILES |
CC(CN1CCC2=CC(=C(C=C21)SC)F)N
|
||||
InChI |
1S/C12H17FN2S/c1-8(14)7-15-4-3-9-5-10(13)12(16-2)6-11(9)15/h5-6,8H,3-4,7,14H2,1-2H3/t8-/m0/s1
|
||||
InChIKey |
IGAAICGMRRWZJW-QMMMGPOBSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | 5-hydroxytryptamine 2C receptor | Target Info | Inhibitor | [527037] | |
5-hydroxytryptamine 2B receptor | Target Info | Inhibitor | [527037] | ||
5-hydroxytryptamine 2A receptor | Target Info | Inhibitor | [527037] | ||
WikiPathways | Serotonin Receptor 2 and ELK-SRF/GATA4 signaling | ||||
Monoamine GPCRs | |||||
GPCRs, Class A Rhodopsin-like | |||||
Gastrin-CREB signalling pathway via PKC and MAPK | |||||
GPCR ligand binding | |||||
GPCR downstream signalingWP732:Serotonin Receptor 2 and ELK-SRF/GATA4 signaling | |||||
GPCR downstream signalingWP733:Serotonin Receptor 2 and STAT3 Signaling | |||||
SIDS Susceptibility Pathways | |||||
GPCR downstream signaling | |||||
GPCRs, Other | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.